Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
adjunctive, advocated, alfa, alongside, AML, architecture, Arizona, Bachelor, baseline, Becerra, BGC, BICR, bifurcated, bifurcation, bolster, bond, branch, Brennan, Brueckl, cargo, Carlo, Catalyst, ceiling, chair, chairperson, Chevron, CIO, Cir, Clark, cleanroom, Connecticut, contractor, CRL, debtor, deceased, depositary, discharged, discretionary, docetaxel, Docket, doctrine, edition, eighteen, enumerated, ERM, ERP, foreclose, foreclosed, foreclosure, forefront, forever, Freeman, FTC, FVO, Gaza, gemcitabine, graft, hematopoietic, hereditary, holistic, Hong, immuno, Indiana, Infinity, intelligence, IPRT, IRA, Kong, levied, lien, Linda, liposomal, logistic, longstanding, lurbinectedin, lymph, Maxwell, MiNK, mismatch, misuse, Montana, Monte, NantXL, neuroendocrine, nogapendekin, nonconvertible, noteholder, Oberland, OFAC, older, online, Oregon, ovarian, Owen, pegylated, penetration, perfected, phishing, plaintiff, posture, pretax, print, PRO, proactive, purview, QMSR, questionnaire, ramucirumab, recapitalization, reconciling, repaid, repayment, Republic, resale, reservoir, resubmission, retaliation, retrospective, RIPA, Rockefeller, safeguard, Salzman, sanitary, scenario, Shionogi, shortage, simulated, Smart, solution, SPOA, statistician, subcontractor, subset, Tennessee, Terminology, ThAnktiva, threshold, trailing, trouble, truthful, turnover, tying, unconstitutional, undermine, underwent, unsecured, uptake, urologic, Utah, ViiV, warehouse, Wesley, woman, writedown, Yemen, younger
Removed:
AB, abraxane, Accountability, advisor, Assembly, AstraZeneca, carcinoma, carrier, characterized, chimeric, chronic, Codiak, Codification, College, compare, computer, consultant, cooperative, COVID, cryopreserved, curtail, deacetylase, deem, degradation, deleted, Dendron, deployment, derive, designing, differentiate, diffuse, distancing, DLBCL, durable, easily, emergency, encouraging, enjoining, epidermal, escalation, floating, GammaDelta, great, head, highest, histone, home, Hospital, immunomodulatory, induced, inducing, inflammation, initiative, Inovio, institution, isolated, killer, Kuur, locally, LP, master, maximal, mechanism, Medigene, monoclonal, neck, neutralizing, Northwest, novavax, optimizing, participant, phenotype, Portability, Precigen, prominent, purportedly, reactogenicity, recipient, selective, stipulation, stored, strain, suppressive, Taxpayer, threatening, TNBC, treaty, underwriting, underwritten, universal, unprecedented, upcoming, vaccination, virally, vote, weather, wrongful
Filing tables
Filing exhibits
IBRX similar filings
Filing view
External links
EXHIBIT 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, David C. Sachs, the chief financial officer of ImmunityBio, Inc. (the “Company”), hereby certify, that, to the best of my knowledge:
i.the Annual Report of the Company on Form 10-K for the year ended December 31, 2023 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
ii.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: March 19, 2024 | By: | /s/ David C. Sachs | ||||||
David C. Sachs | ||||||||
Chief Financial Officer | ||||||||
(Principal Financial Officer) |